Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma.
Morita
Rena
R
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan. r-mori@f3.dion.ne.jp.
Hashino
Satoshi
S
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Shirai
Shinichi
S
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Fujita
Noriaki
N
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Onozawa
Masahiro
M
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Kahata
Kaoru
K
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Kondo
Takeshi
T
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Imamura
Masahiro
M
Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Asaka
Masahiro
M
Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003907:Dexamethasone / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D005938:Glucocorticoids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone